112 related articles for article (PubMed ID: 38182151)
1. Activation of HDAC8 Can Suppress the Proliferation of Osteosarcoma Cells via
Wang L; Bai X; Zhang X; Wang X; Chen S; Wu S; Lin L
Ann Clin Lab Sci; 2023 Nov; 53(6):920-930. PubMed ID: 38182151
[TBL] [Abstract][Full Text] [Related]
2. Effects of FOSL1 silencing on osteosarcoma cell proliferation, invasion and migration through the ERK/AP-1 signaling pathway.
Han Y; Zhao X; Sun Y; Sui Y; Liu J
J Cell Physiol; 2019 Apr; 234(4):3598-3612. PubMed ID: 30471098
[TBL] [Abstract][Full Text] [Related]
3. circHIPK3 promotes proliferation and migration and invasion via regulation of miR‑637/HDAC4 signaling in osteosarcoma cells.
Wen Y; Li B; He M; Teng S; Sun Y; Wang G
Oncol Rep; 2021 Jan; 45(1):169-179. PubMed ID: 33416147
[TBL] [Abstract][Full Text] [Related]
4. LncRNA NORAD accelerates the progression and doxorubicin resistance of neuroblastoma through up-regulating HDAC8 via sponging miR-144-3p.
Wang B; Xu L; Zhang J; Cheng X; Xu Q; Wang J; Mao F
Biomed Pharmacother; 2020 Sep; 129():110268. PubMed ID: 32563146
[TBL] [Abstract][Full Text] [Related]
5. Silencing circular RNA hsa_circABCC1 inhibits osteosarcoma progression through down-regulating HDAC4 via sponging miR-591.
Wang K; Wang N; Liu J; Zhou J; Lei S; Yue H; Feng H; Feng K; Kang X
Environ Toxicol; 2023 Jul; 38(7):1565-1576. PubMed ID: 37052456
[TBL] [Abstract][Full Text] [Related]
6. Alterations in histone deacetylase 8 lead to cell migration and poor prognosis in breast cancer.
Hsieh CL; Ma HP; Su CM; Chang YJ; Hung WY; Ho YS; Huang WJ; Lin RK
Life Sci; 2016 Apr; 151():7-14. PubMed ID: 26926079
[TBL] [Abstract][Full Text] [Related]
7. The up-regulation of histone deacetylase 8 promotes proliferation and inhibits apoptosis in hepatocellular carcinoma.
Wu J; Du C; Lv Z; Ding C; Cheng J; Xie H; Zhou L; Zheng S
Dig Dis Sci; 2013 Dec; 58(12):3545-53. PubMed ID: 24077923
[TBL] [Abstract][Full Text] [Related]
8. HDAC8 overexpression in mesenchymal stromal cells from JAK2+ myeloproliferative neoplasms: a new therapeutic target?
Ramos TL; Sánchez-Abarca LI; Redondo A; Hernández-Hernández Á; Almeida AM; Puig N; Rodríguez C; Ortega R; Preciado S; Rico A; Muntión S; Porras JRG; Del Cañizo C; Sánchez-Guijo F
Oncotarget; 2017 Apr; 8(17):28187-28202. PubMed ID: 28390197
[TBL] [Abstract][Full Text] [Related]
9. (E)-SIS3 suppressed osteosarcoma progression via promoting cell apoptosis, arresting cell cycle, and regulating the tumor immune microenvironment.
Huang Z; Zhang C; Zhu K; Hu J; Xu E; Ma X; Wang Y; Zhu Y; Zhu J
Drug Dev Res; 2023 Dec; 84(8):1751-1763. PubMed ID: 37784254
[TBL] [Abstract][Full Text] [Related]
10. Histone deacetylase 8 is deregulated in urothelial cancer but not a target for efficient treatment.
Lehmann M; Hoffmann MJ; Koch A; Ulrich SM; Schulz WA; Niegisch G
J Exp Clin Cancer Res; 2014 Jul; 33(1):59. PubMed ID: 25011684
[TBL] [Abstract][Full Text] [Related]
11. [Downregulation of Herg1 suppresses osteosarcoma proliferation and invasion by targeting Hippo signaling pathway].
Chen ZD; Ye WB; Zeng WR; Song C; Song W; Zhang YM; Wu J
Zhonghua Zhong Liu Za Zhi; 2019 May; 41(5):338-345. PubMed ID: 31137166
[No Abstract] [Full Text] [Related]
12. [Expression of Ether à go-go 1 and its molecular mechanism of regulating the malignant phenotype of osteosarcoma].
Chen ZD; Liu QJ; Zeng WR; Wu XY; Lin B; Wu J
Zhonghua Zhong Liu Za Zhi; 2016 Nov; 38(11):818-825. PubMed ID: 27998439
[No Abstract] [Full Text] [Related]
13. miRNA-221-3p derived from M2-polarized tumor-associated macrophage exosomes aggravates the growth and metastasis of osteosarcoma through SOCS3/JAK2/STAT3 axis.
Liu W; Long Q; Zhang W; Zeng D; Hu B; Liu S; Chen L
Aging (Albany NY); 2021 Aug; 13(15):19760-19775. PubMed ID: 34388111
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of long non-coding RNA DBH-AS1 inhibits osteosarcoma progression by PI3K-AKT signaling pathways and indicates good prognosis.
Liu ZB; Wang JA; Lv RQ
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1418-1427. PubMed ID: 30840262
[TBL] [Abstract][Full Text] [Related]
15. Aryl hydrocarbon receptor regulates histone deacetylase 8 expression to repress tumor suppressive activity in hepatocellular carcinoma.
Wang LT; Chiou SS; Chai CY; Hsi E; Wang SN; Huang SK; Hsu SH
Oncotarget; 2017 Jan; 8(5):7489-7501. PubMed ID: 27283490
[TBL] [Abstract][Full Text] [Related]
16. Cinobufagin Suppresses The Characteristics Of Osteosarcoma Cancer Cells By Inhibiting The IL-6-OPN-STAT3 Pathway.
Zhang C; Ma K; Li WY
Drug Des Devel Ther; 2019; 13():4075-4090. PubMed ID: 31824138
[TBL] [Abstract][Full Text] [Related]
17. Salidroside suppresses the growth and invasion of human osteosarcoma cell lines MG63 and U2OS in vitro by inhibiting the JAK2/STAT3 signaling pathway.
Huang L; Huang Z; Lin W; Wang L; Zhu X; Chen X; Yang S; Lv C
Int J Oncol; 2019 Jun; 54(6):1969-1980. PubMed ID: 31081055
[TBL] [Abstract][Full Text] [Related]
18. A kinome-wide RNAi screen identifies ALK as a target to sensitize neuroblastoma cells for HDAC8-inhibitor treatment.
Shen J; Najafi S; Stäble S; Fabian J; Koeneke E; Kolbinger FR; Wrobel JK; Meder B; Distel M; Heimburg T; Sippl W; Jung M; Peterziel H; Kranz D; Boutros M; Westermann F; Witt O; Oehme I
Cell Death Differ; 2018 Dec; 25(12):2053-2070. PubMed ID: 29515255
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase inhibitors suppress mutant p53 transcription via HDAC8/YY1 signals in triple negative breast cancer cells.
Wang ZT; Chen ZJ; Jiang GM; Wu YM; Liu T; Yi YM; Zeng J; Du J; Wang HS
Cell Signal; 2016 May; 28(5):506-515. PubMed ID: 26876786
[TBL] [Abstract][Full Text] [Related]
20. HDAC8, A Potential Therapeutic Target, Regulates Proliferation and Differentiation of Bone Marrow Stromal Cells in Fibrous Dysplasia.
Xiao T; Fu Y; Zhu W; Xu R; Xu L; Zhang P; Du Y; Cheng J; Jiang H
Stem Cells Transl Med; 2019 Feb; 8(2):148-161. PubMed ID: 30426726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
